STOCK TITAN
  1. Home
  2. News
  3. BWXT

BWX Technologies, Inc. - BWXT STOCK NEWS

Welcome to our dedicated page for BWX Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on BWX Technologies stock.

BWX Technologies, Inc. (BWXT) is a premier provider of nuclear components and fuel to the U.S. government. The company is renowned for its technical expertise, management, and site services, supporting government operations of complex facilities and environmental remediation activities. BWXT also plays a critical role in the commercial nuclear power industry, offering precision-manufactured components and specialized services.

Headquartered in Lynchburg, Virginia, BWXT has a significant presence with operations in Erwin, Tennessee; Mount Vernon, Indiana; Euclid, Ohio; Barberton, Ohio; Cambridge, Ontario, Canada; and over a dozen U.S. Department of Energy sites around the country. It employs more than 5,200 skilled professionals dedicated to advancing nuclear technology and safety.

BWXT operates in two main segments: Government Operations and Commercial Operations. The Government Operations segment encompasses the legacy Nuclear Operations Group and Nuclear Services Group, focusing on advanced reactor projects and innovative manufacturing techniques. The Commercial Operations segment includes the legacy Nuclear Power Group, which engages in research, development, and commercialization of medical and industrial radioisotopes and radiopharmaceuticals.

The company’s financial health is robust, with a majority of its revenue generated from its Government Operations segment. BWXT’s strategic partnerships and projects aim to enhance its market presence and technological capabilities. Geographically, while the company operates in the United States, Canada, and the United Kingdom, the bulk of its revenue comes from the United States.

Recent achievements highlight BWXT's commitment to innovation and excellence. The company continues to secure significant contracts, invest in cutting-edge technologies, and expand its services in the nuclear sector. These efforts underscore BWXT’s pivotal role in both government and commercial nuclear projects.

News

BWX Technologies Hosting Investor Day and Ringing NYSE Closing Bell

Rhea-AI Summary
BWX Technologies, Inc. (BWXT) hosts Investor Day to discuss business strategies and growth outlook. Management including CEO Rex Geveden will present. The company will also participate in the Closing Bell Ceremony at NYSE.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.87%
Tags
none
-
News

BWX Technologies Reports Fourth Quarter and Full Year 2023 Results, Initiates 2024 Guidance

Rhea-AI Summary
BWXT Technologies, Inc. (BWXT) reported strong financial results for Q4 2023 and full year 2023, with record revenue, net income, and adjusted EBITDA. The company initiated 2024 guidance, expecting continued growth and positive momentum. BWXT also highlighted key achievements in 2023, such as labor force expansion, new program wins, and improved performance in various segments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.87%
Tags
earnings
-
News

BWXT Subsidiary Awarded $122 Million Contract Extension for Uranium Downblending Services

Rhea-AI Summary
BWX Technologies, Inc. (BWXT) secures a $122 million contract extension for downblending highly enriched uranium into low enriched uranium for the Tennessee Valley Authority. The extension spans from July 2025 to June 2027, supporting the National Nuclear Security Administration's defense programs objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.02%
Tags
none
News

BWX Technologies to Announce Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27

Rhea-AI Summary
BWX Technologies, Inc. (BWXT) will release its fourth quarter and full-year 2023 results on February 27, 2024, followed by a conference call and an Investor Day on February 28, 2024. The company encourages participants to join the call and view the presentation online. The event will feature presentations by BWXT's President and CEO, CFO, and other leaders, followed by a live Q&A session. In-person attendance for the Investor Day is by invitation only.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
earnings
-
News

BWXT Names Nicole W. Piasecki to Board of Directors

Rhea-AI Summary
BWX Technologies, Inc. (NYSE: BWXT) announced the appointment of Nicole W. Piasecki, a former Boeing executive, to its board of directors effective January 2, 2024. Piasecki brings 25 years of experience in senior leadership positions at The Boeing Company and currently serves on the boards of BAE Systems and Weyerhaeuser Company. Her expertise in the aerospace and defense sector, as well as international markets, will be valuable for BWXT's growth goals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
management
-
News

BWX Technologies to Host Investor Day on February 28, 2024

Rhea-AI Summary
BWX Technologies, Inc. (NYSE: BWXT) will host an Investor Day on February 28, 2024, at the New York Stock Exchange. The event will feature presentations by President & CEO Rex D. Geveden and CFO Robb A. LeMasters, followed by a live Q&A session. The webcast, replay, and presentation slides will be available on BWXT’s Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
conferences
News

BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology

Rhea-AI Summary
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) and BWXT Medical Ltd. have entered an agreement for the supply of generators to produce actinium-225, a medical isotope used in cancer treatment clinical trials. The agreement allows Fusion to access high-specific activity generator technology to produce actinium-225 at its GMP manufacturing facility, supporting the company's advancing pipeline of targeted alpha therapies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
-
News

Fusion Pharmaceuticals Strengthens Actinium Supply with Onsite Isotope Production through Expanded BWXT Medical Collaboration

Rhea-AI Summary
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) and BWXT Medical Ltd. have entered into a new agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials. This collaboration enables Fusion to produce high purity actinium-225 at the Company's GMP manufacturing facility, further solidifying BWXT Medical's position as a global leader in medical isotope supply. Actinium-225 is an alpha-emitting isotope used in Fusion's targeted alpha therapies (TATs) to kill cancer cells while minimizing the impact to healthy tissues. The agreement allows Fusion to have onsite production of actinium-225, providing superior flexibility in manufacturing schedules and increased capacity to support the clinical pipeline.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
-
News

BWXT Selected as Nuclear Fuel and Component Manufacturer for Air Force Research Laboratory’s JETSON Program

Rhea-AI Summary
BWXT Technologies, Inc. (NYSE: BWXT) has been chosen as the nuclear fuel and components manufacturer for the Air Force Research Laboratory’s JETSON program. This program aims to advance high-power nuclear electric power and propulsion technologies for spacecraft design, offering 6-20 kWe of electricity, four times more than traditional solar arrays without continuous sunlight. BWXT will work with Lockheed Martin and Space Nuclear Power Corporation to lead manufacturing and testing activities, supporting design and system integration.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
News

BWX Technologies Reports Third Quarter 2023 Results

Rhea-AI Summary
BWX Technologies, Inc. reported 3Q23 revenues of $590.0 million, net income of $60.4 million, and adjusted EBITDA of $106.5 million. The company signed multiple agreements to progress microreactor development for commercial applications. They narrowed their 2023 non-GAAP EPS guidance to $2.90-$2.95 and provided preliminary 2024 guidance for mid-single-digit growth in non-GAAP EPS and adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
earnings

FAQ

What is the current stock price of BWX Technologies (BWXT)?

The current stock price of BWX Technologies (BWXT) is $112.14 as of January 29, 2025.

What is the market cap of BWX Technologies (BWXT)?

The market cap of BWX Technologies (BWXT) is approximately 10.4B.

What does BWX Technologies, Inc. (BWXT) specialize in?

BWXT specializes in providing nuclear components and fuel to the U.S. government, supporting complex facility operations, and offering services to the commercial nuclear power industry.

Where is BWXT headquartered?

BWXT is headquartered in Lynchburg, Virginia.

How many employees does BWXT have?

BWXT employs more than 5,200 professionals.

What are the main segments BWXT operates in?

BWXT operates in two main segments: Government Operations and Commercial Operations.

Which segment contributes the most to BWXT's revenue?

The Government Operations segment contributes the most to BWXT's revenue.

Where does BWXT have significant operations?

BWXT has significant operations in Virginia, Tennessee, Indiana, Ohio, and Ontario, as well as at over a dozen U.S. Department of Energy sites.

What are BWXT's recent achievements?

BWXT has secured significant contracts, invested in advanced technologies, and expanded its services in the nuclear sector.

What industries does BWXT serve?

BWXT serves the government, commercial nuclear power, medical, and industrial sectors.

Does BWXT operate internationally?

Yes, BWXT operates in the United States, Canada, and the United Kingdom, with the majority of its revenue coming from the United States.

What kind of services does BWXT provide?

BWXT provides technical, management, and site services for complex facility operations and environmental remediation, along with precision manufacturing for commercial nuclear power.
Stock BWXT logo
BWX Technologies, Inc.

NYSE:BWXT

BWXT Rankings

#853 Ranked by Market Cap
#1876 Ranked by Dividends

BWXT Stock Data

10.44B
91.09M
0.38%
93.75%
1.28%
Aerospace & Defense
Engines & Turbines
Link
United States of America
LYNCHBURG